Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study

Overview of attention for article published in Breast Cancer Research and Treatment, January 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter: 8 X users
f1000: 1 research highlight platform

guideline: 3 clinical guideline sources

Readers on

mendeley: 79 Mendeley

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 6,988 followers.

RT @Emmi_Dack: Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers. https://t.co/Bq0FUPvZAO

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers. https://t.co/Bq0FUPvZAO

Lees interessant nieuws #hormoontherapie is veilig in de #overgang voor #BRCA1 draagsters https://t.co/riN5oEtC8p

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 4 additional X posts.